Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. S. Panobinostat Capsules+>



USA. S. Panobinostat Capsules+>'s subsections
(*) EU CE Mark Date: 2015. 08.28.
(*) USA Approval Date: 2015. 02.23.
+Bortezomib+Dexamethasone
>2 Prior Regimens>Bortezomib &
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 02.23
TradeMark
TradeMark Web-Site

USA. S. Panobinostat Capsules+>'s products
This section has no products